Learn key considerations for rapid initiation of ART. Topics include current recommendations and a discussion of the data to support ART options for rapid initiation.
Jason Halperin, MD, MPH
Jürgen K. Rockstroh, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 2.31 MB
Released: September 29, 2021
Acknowledgements
Educational grant provided by:
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare
Leaving the CCO site
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
